Related Experiment Videos
Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions?
Helena Chmura Kraemer1, Thomas N Robinson
1Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Road, #5717, Stanford, CA 94305, USA. hck@stanford.edu
Contemporary Clinical Trials
|July 5, 2005
Summary
This study examines multicenter randomized clinical trials (RCTs), recommending decentralized collaborative RCTs for efficiency. It advises against ignoring site differences or using centralized models, which can be costly and yield misleading patient data.
Area of Science:
- Clinical Trials Methodology
- Multicenter Study Design
Background:
- Multicenter studies are crucial for robust clinical trial evidence.
- Various structural approaches exist for multicenter randomized clinical trials (RCTs).
Purpose of the Study:
- To evaluate and categorize different structures of multicenter RCTs.
- To recommend optimal designs and identify suboptimal approaches for multicenter research.
Main Methods:
- Discussion and comparative analysis of four distinct multicenter RCT structures.
- Evaluation based on cost-effectiveness, data integrity, and scientific progress.
Main Results:
- Recommends "ideal" multicenter RCTs and decentralized collaborative RCTs as highly effective approaches.
- Identifies multicenter RCTs ignoring site differences and centralized collaborative RCTs as problematic.
Conclusions:
- Decentralized collaborative multicenter RCTs offer significant advantages.
- Suboptimal designs risk misleading results, increased costs, and patient harm, hindering scientific advancement.